Member Info for ennombrede

An ARDS drug is very much needed. FDA did grant fast track designation for Traumakine (RNS 29 Jan 2018):
'Fast Track designation is granted by the FDA to expedite the review and facilitate the development of drugs to treat serious conditions with significant unmet medical need. The purpose of the process is to get new drugs to patients quicker.'

Hear, hear, Drums.

May I ask which broker you use Tiger? Dont know whether it makes much difference, but I spend my time clicking re-quote in a hope to be given a pittance of stock.
Thanks

All he does is ramps as soon as he buys a share that he's seen up on the leader board. Doesnt add any value to the discussion boards at all. My recommendation to him is calm down a bit and offer something of substance when he does comment.

... and one of the lowest cost operators in the sector, and now with a Sovereign Wealth Fund on board as a major shareholder. Will likely trade at a premium multiple vs. peers when in production.

Amazon's t/o of Whole Foods. Whole sector under pressure.

Hey GW, you recommended I do some research on this co about maybe a month back, when I said I was looking around for an investment (ended up buying some shares in a French stock which are doing well thankfully). I havent actually conducted the proper research to have bought any here myself. But glad you're doing well. I think you did suggest HAYT must be considered as a takeover target. Best wishes (ps hope the other co that we do have a both have an interest in gets something materially concrete soon... the hope value in the sp evaporates weekly).

Red Leg takes Gold in Spiced Rum Division http://www.thespiritsbusiness.com/2017/03/the-rum-masters-2017-results/

Interesting comment by owenski 08:54 this morning. http://uk.advfn.com/stock-market/london/software-radio-technology-SRT/share-chat Would be great to see Positive Momentum kick-in; the upside could be huge. The RNS this morning both reinforces upside calls, plus de-risks the investment. Looking at finally building a position for the first time.

Scratch that, they didn't take part in the placing I think I read that as.

Henderson sells (takes some profit while there is good demand from the buyside - enough that the stock continues higher).

Ive re-watched it twice! https://www.youtube.com/watch?v=ffkVPwUzf4g Good stuff. Glad to see us over a quid finally... Seems like it took forever. Hopefully Revenue of over £1bn, reasonable margins, and most importantly improvements in early detection and treatment for patients very soon. Best wishes all holders. I read the comments daily and appreciate the contributions.

Thanks MissBMW for sharing that. Buccaneer (Re 'Raising Awareness' post on Tues) if the DailyMail is your preferred publication then well done.

Hi Peekayokay. Yeah I agree, the sp and placement price probably would have been higher - it certainly wasn't a positive. The lens and benefit of hindsight records things differently sometimes to the intentions of participants. Theres been shares used as collateral for years. Shareholders didn't have an issue with the transaction (and those of other directors elsewhere - such as at IQE) until weeks later when questionable Rob Terry defending against a short attack on also questionable QPP shares also entered into a similar agreement with the same lender. Oh well. The cheap valuation is helpful to those wanting to add. The upside is huge. Best wishes

Of course not meant to be disrespectful, just felt 'Stupidity' was a rather strong comment, unless of course you were referring to somethings that im unaware of.

Hi Peekayokay. Youre probably referring to the share deal. Theres been a number of the same type of transaction that appear fair enough bona fide to me, in some companies that have done well since (not referring to QPP). To be actually honest, maybe naively I read it positively when the RNS came out viewing it as Andrew Newland desiring not to sell any stock, not of course recognising that in theory the vehicle was open to abuse as highlighted during the Rob Terry debacle whose character can very well be questioned. I also think some of us in directorships with the requirement for short term funds may well have entered the same transaction without looking at loop holes etc. I wouldn't attribute that to stupidity. But yes it sure was unfortunate to coincide with the QPP mess, and put AGL's share price (and thus potential for the then pending equity fundraising) at risk

A little surprised the stock is not trading above 2014 highs (though notably theres been a fundraising since then). Medtech companies experience reasonable margins, and looking at large caps they tend to trade between 2.4x to just over 4x sales, though obviously theres no apples for apples comparison. The current market valuation of Angle (EV of less than £50mn, no near term funding requirement and current professional collaborators' comments about Parsortix) discounts a great deal in comparison to the upside. The upside of course being revenues of over £1bn a year, and seeing the product genuinely help people. That's my ramp if it counts as one : ) Theres risks ahead and execution may be very different to my rosy upside outlook.

No probs MissBMW. Nice to hear the thoughts of Newland on the potential annual revenue from its use for Breast Cancer (a multiple of the £300mn per annum mentioned in regard to Ovarian) from a shareholder point of view, which is in the big picture just secondary to the health benefit potential and the financial savings to healthcare. Congratulations to the whole team and the research institutions such as the Med Uni of Vienna. I don't normally comment, but todays RNS (following consecutive good news), reminds us that we're involved in something very special. I know many of us actually found it a privilege to take part in the recent Equity Offer to existing shareholders.

http://www.proactiveinvestors.co.uk/companies/stocktube/3691/angle-boss-on-breakthrough-ovarian-cancer-results-3691.html?hootPostID=f11ff434bc346b08dcab5751c69dfa16 ANGLE boss on breakthrough ovarian cancer results By Nigel Roberts April 21 2015, 12:48pm

Betfair suffering a DDoS attack